Clinical TrialsSearch results
Number of results: 595
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Recruiting
- A Phase 2 Study of MK-3475A in Japanese Participants with Recurrent or Metastatic (R/M) or Locally Advanced (LA) unresectable Cutaneous Squamous Cell Carcinoma (cSCC)
- Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma or Locally Advanced unresectable cSCC
- Fujita Tomoko
- 2023-09-04
Other
- A Phase 2/3 Study of SYR-322 as an Add-on to a Metformin
- Type 2 diabetes mellitus
- Takeda Pharmaceutical Company Limited
- 2009-04-01
Other
- A Phase 2/3 Study of SYR-322 as an Add-on to a Sulfonylurea
- Type 2 diabetes mellitus
- Takeda Pharmaceutical Company Limited
- 2009-04-01
Other
- A Phase 2/3 Study of SYR-322 as an Add-on to a Thiazolidine
- Type 2 diabetes mellitus
- Takeda Pharmaceutical Company Limited
- 2008-10-01
Other
- A Phase 2/3 Study of SYR-322 as an Add-on to an Alpha-Glucosidase Inhibitor
- Type 2 diabetes mellitus
- Takeda Pharmaceutical Company Limited
- 2008-10-01
Other
- A Phase 3 Clinical Study of TS-071 in Paediatric Patients with Type 2 Diabetes Mellitus
- Type 2 diabetes mellitus
- Mita Seiji
- 2020-12-15
Other
- A Phase 3 study of NPC-06 in Patients With Pain Associated with acute Herpes Zoster
- Pain Associated with acute Herpes Zoster
- Saori Arai
- 2022-07-30
Other
- A Phase I Dose Intensification Study of three dimentional conformal thoracic radiotherapy with concurrent cisplatin and TS-1 for unresectable stage III non-small cell lung cancer
- non-small cell lung cancer
- Shizuoka Cancer Center, The Cancer Institute Hospital of JFCR
- 2008-12-02
Completed
- A phase I study of chemoradiotherapy using CBDCA + nab-PTX for elderly stage III NSCLC
- Clinical stage III non-small-cell lung cancer
- Takahashi Toshiaki
- 2019-03-11
Completed
- A Phase I study of irinotecan, bevacizumab and TAS-102 for metastatic colorectal cancer patients
- unresectable metastatic colorectal cancer
- Yamazaki Kentaro
- 2019-01-22